Genentech's Gazyva gains indication for idiopathic nephrotic syndrome
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK
Key PointsThe iShares Biotechnology ETF carries a lower expense ratio and significantly larger assets under management (AUM) than the Simplify Health Care ETF.
Wall Street climbs as investors buy AI stocks; Microsoft rallies
Wall Street climbed on Friday, lifted by Microsoft and other AI-related technology stocks, while high oil prices and a recent surge in U.S. Treasury yields kept investors on edge.
Circle and Tether Freeze Stablecoins Tied to Bitget Hack—But Most Funds Slip Away
The two stablecoin issuers blacklisted a wallet labeled "Bitget Exploiter 8," locking about $318,000 in USDC and USDT—but the attacker swapped most funds into unfreezable ETH before they could act.